CaliberMRI announces release of a preclinical quantitative MRI phantom (T1, T2, ADC) for high-field systems

Transforming MRI to advance precision medicine

BOULDER, Colo., Nov. 10, 2026 /PRNewswire/ -- CaliberMRI, an industry leader in standardizing Magnetic Resonance Imaging (MRI), announces release of a quantitative MRI phantom compatible with high-field preclinical scanners. Features of the Model 340 include:

• 59mm diameter;
• range of NIST-traceable T1, T2, and ADC calibration solutions;
• resolution coupon with hole patterns in diameters from 0.4 mm to 1.2 mm; and
• CaliberMRI's patented MR readable LC Thermometer. 

"We are excited to support the field with our preclinical phantom and provide an opportunity for sites to compare across field strengths - particularly in smaller coils and at 4.7T, 7T, and 9.4T," says William Hollander, CEO of CaliberMRI. "We are seeing increasing interest from a broad variety of customers and collaborators implementing qMRI on preclinical scanners and on scanners with smaller bore sizes,"  Hollander added.  This phantom, which complements CaliberMRI's standard phantom line, provides another opportunity to improve data quality, standardization, harmonization, and reproducibility.  

About: CaliberMRI is on a mission to improve standardization of qMRI.  CaliberMRI produces integrated phantom/software platforms to ensure quantitative MRI measurements are accurate, repeatable and reproducible.  CaliberMRI's qCal-MR®, an automated QA/QC analysis software, supports phantom scan analysis on more than 50 MRI scanner makes and models at a variety of field strengths from 64mT to 7T.  The Company's products were developed in collaboration with the National Institute of Standards and Technology (NIST), Radiological Socity of North America (RSNA), and the International Society for Magnetic Resonance in Medicine (ISMRM). More than 300 papers and abstracts cite CaliberMRI products on topcs including quantitative imaging biomarkers, repeatability and reproducibility, R&D, protocol and sequence development, QA/QC, and AI/ML testing and validation.  Based in Boulder, Colorado, the company works with researchers, hospitals, industry, and clinicians around the world and has a growing distributor network.  For more information on our products and mission, visit our website, follow us on LinkedIn, or reach out to set up a meeting at RSNA's annual meeting in Chicago November 29th - December 2nd.

Contact:
Callie Weiant, President
sales[at]qmri.com 

SOURCE CaliberMRI, Inc.